1. Introduction

Novel therapy approval by courts arises when a patient seeks access to:

• Experimental medical treatment
• Unapproved drugs or procedures
• Innovative life-saving therapies not yet fully authorized by regulators
• Compassionate use or “last resort” treatments

Courts are called upon when there is conflict between:

• Patient’s right to life and health (Article 21)
• Medical ethics and safety standards
• Regulatory approval requirements (Drugs Controller / clinical trial rules)

Such cases typically involve:

• Terminal illness
• Rare diseases
• Lack of standard treatment options
• High-risk experimental procedures

2. Legal Framework in India

(A) Constitution of India – Article 21

Includes:

• Right to life
• Right to health
• Right to dignity
• Right to access medical treatment

(B) Drugs and Cosmetics Act, 1940

• Regulates approval of drugs and therapies
• Experimental drugs require regulatory clearance

(C) New Drugs and Clinical Trials Rules, 2019

• Governs clinical trials and “compassionate use”
• Requires ethics committee approval

(D) Indian Council of Medical Research (ICMR) Guidelines

• Ethical standards for experimental treatment
• Informed consent mandatory

(E) Mental Healthcare Act, 2017 (where relevant)

• Emphasizes informed consent and autonomy

3. When Courts Consider Approval of Novel Therapy

Courts intervene when:

• Treatment is life-saving but unapproved
• Patient has exhausted all standard therapies
• Clinical trial participation is unavailable
• Government approval is delayed or denied
• Ethical ambiguity exists in experimental procedure

4. Principles Governing Judicial Approval

Courts apply strict balancing principles:

• Right to life vs medical risk
• Informed consent is mandatory
• Patient autonomy is central
• Treatment must have scientific plausibility
• No violation of public health regulations
• Risk-benefit analysis is essential
• Courts avoid substituting medical expertise

5. Important Case Laws (At Least 6)

1. Suchita Srivastava v. Chandigarh Administration (2009, Supreme Court of India)

• Though primarily reproductive rights case, it is foundational for medical autonomy.

Principle: Medical decisions are part of personal liberty under Article 21; informed consent is essential for any intervention.

2. Aruna Shanbaug v. Union of India (2011, Supreme Court of India)

• Addressed medical treatment decisions for incapacitated patients.

Principle: Courts may authorize or restrict medical interventions based on patient dignity and best interest.

3. Common Cause v. Union of India (2018, Supreme Court of India)

• Recognized right to passive euthanasia and advance directives.

Principle: Patient autonomy in medical treatment decisions is constitutionally protected, relevant to experimental therapies.

4. K.S. Puttaswamy v. Union of India (2017, Supreme Court of India)

• Landmark privacy judgment.

Principle: Bodily autonomy and informed medical choice are fundamental rights, including access to experimental treatments.

5. Roche Products (India) Pvt. Ltd. v. Drugs Controller General of India (Delhi High Court, 2018)

• Related to access to life-saving cancer drugs and regulatory approval.

Principle: Courts may balance regulatory control with right to life in exceptional medical necessity cases.

6. Amit Kumar v. Union of India (Delhi High Court, 2020 – COVID context)

• Concerned emergency access to experimental treatment protocols.

Principle: In extraordinary circumstances, courts may permit compassionate or experimental treatment when life is at risk.

7. Selvi v. State of Karnataka (2010, Supreme Court of India)

• Addressed involuntary medical procedures (narco-analysis etc.)

Principle: Non-consensual medical interventions violate Article 21; applies to experimental therapy approvals.

8. X v. Union of India (2022, Supreme Court of India)

• Expanded medical autonomy in reproductive health decisions.

Principle: Autonomy in medical decisions includes right to choose treatment options within legal limits.

6. Judicial Approach to Novel Therapy Requests

Courts typically follow a three-step test:

Step 1: Medical Necessity

• Is the condition life-threatening or irreversible?

Step 2: Scientific Plausibility

• Is there credible medical evidence supporting therapy?

Step 3: Risk-Benefit Balance

• Do potential benefits outweigh risks?

7. Role of Medical Boards in Court Decisions

Courts often appoint:

• Expert medical committees
• Hospital ethics boards
• Regulatory authority panels

They assess:

• Safety profile
• Experimental validity
• Alternative treatments
• Ethical compliance

Courts generally rely heavily on these reports.

8. Ethical and Legal Safeguards

• Mandatory informed consent
• No coercion of patient or family
• Disclosure of risks and uncertainty
• Monitoring during treatment
• Right to withdraw consent
• Compliance with clinical trial norms

9. Limitations on Court Approval

Courts avoid:

• Approving unscientific or pseudoscientific therapies
• Overriding drug regulatory authority without justification
• Endorsing unsafe human experimentation
• Replacing expert medical judgment

10. Key Legal Principles

• Right to life includes right to medical treatment
• Autonomy and informed consent are fundamental
• Courts act as protectors, not medical decision-makers
• Regulatory compliance is essential
• Experimental therapy requires strict safeguards
• Patient welfare is the central consideration

11. Conclusion

Court approval for novel therapy lies at the intersection of constitutional rights, medical ethics, and regulatory law. Indian courts recognize that while innovation in medicine is essential, it must be balanced with safety and scientific rigor. Judicial intervention is rare and reserved for exceptional cases where life-saving treatment is unavailable. The guiding principle remains that patient autonomy, dignity, and informed consent must coexist with medical caution and regulatory discipline.